CTAD
@CTADconference
The Clinical Trials on Alzheimer's Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials
ID:852545521499635712
http://www.ctad-alzheimer.com 13-04-2017 15:34:26
5,8K Tweets
2,9K Followers
368 Following
DAC has partnered with Scientific American to produce a special issue focused on Alzheimer's disease, featuring contributions from Bill Gates, former NIH director Elias Zerhouni, and other incredible global health and aging leaders. Find the full issue here:
scientificamerican.com/custom-media/t…
Join us in Madrid on October 29 – November 1, 2024!
Secure your in-person registration today
secure.key4events.com/key4register/c…
#Alzheimers #research #therapeutics #drugdevelopment
Do not miss the chance to present your work on Alzheimer’s Disease Clinical Trials in Madrid!
Discover our different submission categories and topics.
Deadline to submit: June 4, 2024
ctad-alzheimer.com/call-abstracts…
#Alzheimers #research #therapeutics #drugdevelopment
Join us in Madrid on October 29 – November 1, 2024!
Secure your in-person registration today
secure.key4events.com/key4register/c…
#Alzheimers #research #therapeutics #drugdevelopment
Do not miss the chance to present your work on Alzheimer’s Disease Clinical Trials in Madrid!
Discover our different submission categories and topics.
Deadline to submit: June 4, 2024
ctad-alzheimer.com/call-abstracts…
#Alzheimers #research #therapeutics #drugdevelopment
Request for Information: NIH Office of Data Science Strategy seeks public input on Proposed Use of Common Data Elements (CDEs) for NIH-Funded Clinical Research and Trials | Closing date for responses: April 20, 2024: datascience.nih.gov/cde-rfi
Countering brain decline in old individuals in 'Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche.' Nat Aging (2024). doi.org/10.1038/s43587… Bruno Vellas Isabelle ADER Philippe Valet Infinity Toulouse I2MC-Toulouse Laure Rouch
Microglia expressing the inhibitory receptor LILRB4 laze around plaques in #Alzheimersdisease and amyloidosis mice. An antibody against LILRB4 stirred microglia to engulf Aβ fibrils and lower plaque load. Washington University in St. Louis ow.ly/7zvU50RexJh
New publication from @I2MCT and IHU HealthAge Team in Toulouse at INSPIRE Platform - IHU HealthAge 'Targeting Gi-coupled P2Y13 receptor in adipose tissue may help combat age-associated metabolic disorders, including #diabetes and liver diseases #MASLD .'
insight.jci.org/articles/view/…
Martinez Laurent
👏Great launch for the IHU HealthAge Toulouse by its founder Professor Bruno Vellas #healthylongevity #geroscience INSPIRE Platform - IHU HealthAge UT3 Paul Sabatier CHU de Toulouse Inserm Occitanie Méditerranée